THEME: "Empowering the Future of Healthcare Through Pharma Innovation"
17-18 Nov 2025
Dubai, UAE Neurodegenerative
diseases are defined as hereditary and sporadic conditions which are
characterized by progressive nervous system dysfunction. All neurodegenerative
disorders involve abnormal processing of neuronal
proteins. The aberrant mechanism can entail a misfolding of proteins,
altered post-translational modification of newly synthesized proteins, abnormal
proteolytic cleavage, anomalous gene splicing, improper expression, or
diminished clearance of degraded protein. Misprocessed proteins often
accumulate because the cellular mechanisms for removing them are ineffective. These
disorders are often associated with atrophy of the affected central or
peripheral structures of the nervous
system.
·
Parkinson’s disease
·
Alzheimer’s disease
·
Huntington’s disease
·
Amyotrophic lateral sclerosis